The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Cell and Gene Therapy Market Between 2026 And 2030?
The cell and gene therapy market has experienced exponential growth in its size over recent years. Projections indicate it will expand from $21.33 billion in 2025 to $26.21 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 22.9%. Historically, this expansion has been driven by factors such as the restricted availability of cell and gene therapies, a prevailing dependence on traditional treatment options, the significant expense associated with initial therapeutic generations, a rising prevalence of oncology and neurological conditions, and an insufficient number of dedicated treatment centers.
The cell and gene therapy market is projected to experience rapid expansion in the coming years. This market is set to reach $60.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth during the forecast period include the advancement of car-t and genome editing therapies, the proliferation of clinical trials and research initiatives, the growing acceptance of personalized medicine, enhanced government backing and financial aid for rare disease treatments, and the incorporation of digital solutions for tracking therapies and managing patients. Key trends anticipated during this period involve the wider uptake of car-t and stem cell therapies, increased financial commitment to gene therapy for oncology and rare diseases, an increase in personalized and targeted cell-based treatments, the proliferation of hospitals and ambulatory surgical centers providing cutting-edge therapies, and the incorporation of genome editing and viral vector-based technologies into clinical applications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp
What Leading Drivers Are Supporting The Cell and Gene Therapy Market Expansion?
The increasing volume of active clinical trials is anticipated to drive the expansion of the cell and gene therapy market in the future. These trials represent investigations carried out involving human subjects to assess the safety and efficacy of novel medical approaches, treatments, or diagnostic methods. They are crucial for the progress and evolution of cell and gene therapy, offering a secure and regulated setting for evaluating emerging therapies and gathering information regarding their safety and effectiveness. An example of this trend is observed in December 2024, where the Association of the British Pharmaceutical Industry (ABPI), an organization based in the UK, reported an increase in pharmaceutical industry trials initiated in the UK for the second year in a row, escalating from 411 in 2022 to 426 in 2023. Consequently, the rising count of active clinical trials serves as a key driver for the expansion of the cell and gene therapy market.
Which Segment Classifications Are Used In The Cell and Gene Therapy Market Segment Analysis?
The cell and gene therapy market covered in this report is segmented –
1) By Product: Cell Therapy, Gene Therapy
2) By Application: Oncology, Neurological Disorders, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
Subsegments:
1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy
What Market Trends Are Affecting The Cell and Gene Therapy Market?
Leading companies operating in the cell and gene therapy market are increasingly focusing on implementing agnostic systems to gain a competitive advantage. Agnostic systems are those designed to integrate with a diverse range of different cell and gene therapy (CGT) software platforms, as well as biopharmaceutical or provider-facing platforms. For instance, in April 2023, AmerisourceBergen, a US-based healthcare company, launched the Cell and Gene Therapy Integration Hub. This new platform-agnostic system is intended to improve connectivity throughout the cell and gene therapy (CGT) treatment journey, thereby enabling an enhanced patient and provider experience. The hub, powered by the company’s customer relationship management system, is engineered to accelerate the benefits investigation process, provide a real-time view of therapy development and transportation status, and assist in coordinating patient support.
Which Firms Are Contributing To The Cell and Gene Therapy Market Ecosystem?
Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca
Get The Full Cell and Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Which Region Represents The Largest Share Of The Cell and Gene Therapy Market?
North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell and Gene Therapy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Browse Through More Reports Similar to the Global Cell and Gene Therapy Market 2026, By The Business Research Company
Cancer Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Nucleic Acid Based Gene Therapy Market Report 2026
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model